NAPM/GPhA Merger Likely Ends Generic User Fees Push In 107th
This article was originally published in The Tan Sheet
Executive Summary
The merger agreement between the National Association of Pharmaceutical Manufacturers and the Generic Pharmaceutical Association likely means generic drug user fees will not be a focal point of the PDUFA reauthorization process.